A cross-sectional assessment of utilization of addiction treatment among injection drug users in Kabul, Afghanistan

Substance Use and Misuse

Volumn 44, Issue 3, 2009, Pages 416-430

  Todd, Catherine S ^a,e   Abed, Abdullah M S ^b   Scott, Paul T ^c   Safi, Naqibullah ^b   Earhart, Kenneth C ^d   Strathdee, Steffanie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ministry of Public Health   (Afghanistan)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d US Naval Medical Research Unit No 3 Egypt   (Egypt)

^e Mailstop 0622 ^*  (United States)

Author keywords

Addiction treatment; Afghanistan; Detoxification; Injecting drug user; Needle exchange program

Indexed keywords

ADOLESCENT; AFGHANISTAN; CROSS-SECTIONAL STUDIES; HUMANS; INTERVIEWS AS TOPIC; MALE; METABOLIC DETOXICATION, DRUG; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 61649100496     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802347669     Document Type: Article

References (34)

1. Antela, A., Casado, J. L., Gonzalez, M. J., Perez, P., Perez-Elias, M. J., Montilla, P., Buzon, L. (1997). Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease. AIDS, 11(11):1405-1406.
2. Azim, T., Hussein, N., Kelly, R. (2005). Effectiveness of harm reduction programmes for injecting drug users in Dhaka city. Harm Reduction Journal, 2:22.
3. Bastos, F. I., Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science and Medicine, 51(12):1771-1782.
4. Caplehorn, J. R., Dalton, M. S., Haldar, F., Petrenas, A. M., Nisbet, J. G. (1996). Methadone maintenance and addicts' risk of fatal heroin overdose. Substance Use and Misuse, 31(2):177-196.
5. Central Intelligence Agency. (2005). The World Factbook: Afghanistan. [https://www.cia.gov/library/publications/the-world-factbook/geos/af.html#Econ] Downloaded August 19, 2007.
6. Central Statistics Office (CSO). (2007). Annual Report, Kabul-Afghanistan. [http://www.cso.gov.af/Census/census.htm]. Central Statistics Office, Kabul, Afghanistan. Downloaded July 31, 2007.
7. Choopanya, K., Des Jarlais, D. C., Vanichseni, S., Mock, P. A., Kitayaporn, D., Sangkhum, U., Prasithiphol, B., Hiranrus, K., van Griensven, F., Tappero, J. W., Mastro, T. D. (2003). HIV risk reduction in a cohort of injecting drug users in Bangkok, Thailand. Journal of Acquired Immune Deficiency Syndrome 33(1):88-95.
8. Chouvy, P. A.: Golden Crescent. In Encyclopedia of Modern Asia. 1st Edition. Edited by Levinson, D., Christensen K. Chicago: Chas. Scribner & Sons; 2002. Pg. 441.
9. Frantz, D. (2000). Bishkek Journal; Heroin and Needles: Battling AIDS in Central Asia. [http://query.nytimes.conVgst/fullpage.html?sec=health&res= 9E03E2D7113FF935 A25753-C1A9669C8B63]. New York Times, New York, Downloaded February 12, 2007.
10. German Technical Cooperation (GTZ). Emerging Practices for the Treatment and Prevention of Drug Dependence in Afghanistan. Integrated Drug Prevention, Treatment, and Rehabilitation Project in Afghanistan (IDPA). Wali Computer and Printing Press, Kabul, Afghanistan.
11. Hankins, C. A., Friedman, S. R., Zafar, T., Strathdee, S. A. (2002). Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS, 16(17):2245-2252.
12. He, N., Detels, R. (2005). The HIV epidemic in China: history, response, and challenge. Cell Research, 15(11-12):825-832.
13. IRIN News. (2002). Afghanistan: Focused on the internally displaced. [http://www.irinnews.org/InDepthMain.aspx?InDepthId=41&ReportId= 70993&Country=Yes] United Nations Office for Coordination of Humanitarian Affairs. Downloaded August 19, 2007.
14. Joint United Nations Program on AIDS (UNAIDS). (2006). AIDS Epidemic Update. UNAIDS, Geneva.
15. Kerr, T., Wodak, A., Elliott, R., Montaner, J. S., Wood, E. (2004). Opioid substitution and HIV/AIDS treatment and prevention. Lancet, 364(9449):1918-1919.
16. Kumaranayake, L., Vickerman, P., Walker, D., Samoshkin, S., Romantzov, V., Emelyanova, Z., Zviagin, V., Watts, C. (2004). The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus. Addiction, 99(12):1565-1576.
17. Liu, H., Grusky, O., Zhu, Y., Li, X. (2006). Do drug users in China who frequently receive detoxification treatment change their risky drug use practices and sexual behavior? Drug and Alcohol Dependence, 84(1):114-121.
18. Metzger, D. S., Woody, G. E., McLellan, A. T., O'Brien, C. P., Druley, P., Navaline, H., DePhilippis, D., Stolley, P., Abrutyn, E. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome, 6(9):1049-1056.
19. Moatti, J. P., Carried, M. P., Spire, B., Gastaut, J. A., Cassuto, J. P., Moreau, J. (2000). Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS, 14(2):151-155.
20. North, A. (2005). Refugees make do in Kabul's ruins. [http://news.bbc.co. uk/l/hi/world/south-asia/4269551.stm] BBC News, London, England. Downloaded August 19, 2007.
21. Peters, A., Davies, T., Richardson, A. (1998). Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices. Addiction, 93(2):253-267.
22. Platt, L., Hickman, M., Rhodes, T., Mikhailova, L., Karavashkin, V., Vlasov, A., Tilling, K., Hope, V., Khutorksoy, M., Renton, A. (2004). The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction, 99(11):1430-1438.
23. Strathdee, S. A., Stachowiak, J. A., Todd, C. S., Al-Delaimy, W. K., Wiebel, W., Hankins, C., Patterson, T. L. (2006). Complex emergencies, HIV, and substance use: no "big easy" solution. Substance Use and Misuse 41(10-12):1637-1651.
24. Todd, C. S., Safi, N., Strathdee, S. A. (2005). Drug use and harm reduction in Afghanistan. Harm Reduction Journal, 2:13.
25. United Nations Childrens Fund (UNICEF). (2007). Afghanistan: statistics. Available at: http://www.unicef.org/infobycounlTv/afghanistan-afghanistan- statistics.html. Accessed August 9, 2007.
26. United Nations Office on Drugs and Crime (UNODC). (2003). Community Drug Profile #5: An assessment of problem drug use in Kabul city. UNODC, Kabul, Afghanistan.
27. United Nations Office on Drugs and Crime (UNODC). (2005). Afghanistan Drug Abuse Survey 2005. UNODC, Kabul, Afghanistan.
28. United Nations Office on Drugs and Crime. (2006). Afghan opium cultivation soars 59 percent in 2006, UNODC survey shows. Available at: http://www.unodc.org/unodc/press-release-2006-09-01.html. Downloaded January 16, 2007.
29. Vazirian, M., Nassirimanesh, B., Zamani, S., Ono-Kihara, M., Kihara, M., Ravari, S. M., Gouya, M. M. (2005). Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: a cross-sectional study. Harm Reduction Journal, 2:19.
30. Vickerman, P., Kumaranayake, L., Balakireva, O., Guinness, L., Artyukh, O., Semikop, T., Yaremenko, O., Watts, C. (2006). The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine. Sexually Transmitted Diseases, 33(10 Suppl):S89-S102.
31. Wodak, A., Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Substance Use and Misuse, 41(6-7):777-813.
32. World Health Organization. (2004a). Best practice in HIV/AIDS prevention and care for injecting drug abusers: the Triangular Clinic in Kermanshah, Islamic Republic of Iran. WHO, Regional Office for the Eastern Mediterranean. Cairo.
33. World Health Organization (WHO)/United Nations Joint Commission on AIDS (UNAIDS)/UNODC position paper. (2004b). Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. WHO, Geneva.
34. WHO Technical Report Series. (2006). The selection and use of essential medicines. WHO, Geneva.